Skip to content
10-Q

Quarterly Report

Pharma-Bio Serv, Inc. PBSV

0001654954-25-010775

← back to feed
Filed
Sep 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Sep 10, 2025 22.92M sh
Shares Diluted Q3 2025 · Jul 31, 2025 22.94M sh
Shares Diluted Q3 2025 · Jul 31, 2025 22.96M sh
Shares Diluted Q3 2025 · Jul 31, 2024 22.96M sh
Shares Diluted Q3 2025 · Jul 31, 2024 22.98M sh
Stock Repurchased Q3 2025 · Jul 31, 2025 $5K
Stock Repurchased Q3 2025 · Jul 31, 2025 $22.24K
Stock Repurchased Q3 2025 · Jul 31, 2024 $1.75K
Stock Repurchased Q3 2025 · Jul 31, 2024 $11.26K
Dividends Paid Q3 2025 · Jul 31, 2025 $0
Dividends Paid Q3 2025 · Jul 31, 2025 $1.72M
Dividends Paid Q3 2025 · Jan 28, 2025 $1.72M
Dividends Paid Q3 2025 · Jul 31, 2024 $0
Dividends Paid Q3 2025 · Jul 31, 2024 $1.72M
Capex Q3 2025 · Jul 31, 2025 $2.04K
Capex Q3 2025 · Jul 31, 2025 $6.29K
Capex Q3 2025 · Jul 31, 2024 $1.91K
Capex Q3 2025 · Jul 31, 2024 $2.73K
Operating Cash Flow Q3 2025 · Jul 31, 2025 $236.52K
Operating Cash Flow Q3 2025 · Jul 31, 2025 −$494.55K
Operating Cash Flow Q3 2025 · Jul 31, 2024 −$670.33K
Operating Cash Flow Q3 2025 · Jul 31, 2024 −$645.13K
Stockholders Equity Q3 2025 · Jul 31, 2025 $11.93M
Stockholders Equity Q3 2025 · Apr 30, 2025 $12.12M
Stockholders Equity Q3 2025 · Oct 31, 2024 $13.72M
Stockholders Equity Q3 2025 · Jul 31, 2024 $13.69M
Stockholders Equity Q3 2025 · Apr 30, 2024 $13.95M
Stockholders Equity Q3 2025 · Oct 31, 2023 $16.13M
Current Liabilities Q3 2025 · Jul 31, 2025 $1.66M
Current Liabilities Q3 2025 · Oct 31, 2024 $1.89M
Total Liabilities Q3 2025 · Jul 31, 2025 $1.66M
Total Liabilities Q3 2025 · Oct 31, 2024 $2.58M
Current Assets Q3 2025 · Jul 31, 2025 $13.16M
Current Assets Q3 2025 · Oct 31, 2024 $15.7M
Total Assets Q3 2025 · Jul 31, 2025 $13.59M
Total Assets Q3 2025 · Oct 31, 2024 $16.29M
Eps Diluted Q3 2025 · Jul 31, 2025 $0.01
Eps Diluted Q3 2025 · Jul 31, 2025 $0.00
Eps Diluted Q3 2025 · Jul 31, 2024 $0.01
Eps Diluted Q3 2025 · Jul 31, 2024 $0.04
Sga Expense Q3 2025 · Jul 31, 2025 $888.14K
Sga Expense Q3 2025 · Jul 31, 2025 $2.67M
Sga Expense Q3 2025 · Jul 31, 2024 $1.02M
Sga Expense Q3 2025 · Jul 31, 2024 $2.92M
Net Income Q3 2025 · Jul 31, 2025 −$204.25K
Net Income Q3 2025 · Jul 31, 2025 −$100.36K
Net Income Q3 2025 · Jul 31, 2024 −$309.19K
Net Income Q3 2025 · Jul 31, 2024 −$793.73K
Operating Income Q3 2025 · Jul 31, 2025 −$313.88K
Operating Income Q3 2025 · Jul 31, 2025 −$504.39K
Operating Income Q3 2025 · Jul 31, 2024 −$381.78K
Operating Income Q3 2025 · Jul 31, 2024 −$1.13M
Gross Profit Q3 2025 · Jul 31, 2025 $574.26K
Gross Profit Q3 2025 · Jul 31, 2025 $2.16M
Gross Profit Q3 2025 · Jul 31, 2024 $635.38K
Gross Profit Q3 2025 · Jul 31, 2024 $1.79M
Cost Of Revenue Q3 2025 · Jul 31, 2025 $1.39M
Cost Of Revenue Q3 2025 · Jul 31, 2025 $4.69M
Cost Of Revenue Q3 2025 · Jul 31, 2024 $1.78M
Cost Of Revenue Q3 2025 · Jul 31, 2024 $5.39M
Revenue Q3 2025 · Jul 31, 2025 $1.96M
Revenue Q3 2025 · Jul 31, 2025 $6.85M
Revenue Q3 2025 · Jul 31, 2024 $2.42M
Revenue Q3 2025 · Jul 31, 2024 $7.18M